156 related articles for article (PubMed ID: 31654956)
1. Hepatocellular carcinoma: Impact of academic setting and hospital volume on patient survival.
Uhlig J; Sellers CM; Khan SA; Cha C; Kim HS
Surg Oncol; 2019 Dec; 31():111-118. PubMed ID: 31654956
[TBL] [Abstract][Full Text] [Related]
2. Hospital Volume and Survival After Hepatocellular Carcinoma Diagnosis.
Mokdad AA; Zhu H; Marrero JA; Mansour JC; Singal AG; Yopp AC
Am J Gastroenterol; 2016 Jul; 111(7):967-75. PubMed ID: 27166130
[TBL] [Abstract][Full Text] [Related]
3. Opportunities to Improve Care of Hepatocellular Carcinoma in Vulnerable Patient Populations.
Hoehn RS; Hanseman DJ; Dhar VK; Go DE; Edwards MJ; Shah SA
J Am Coll Surg; 2017 Apr; 224(4):697-704. PubMed ID: 28069526
[TBL] [Abstract][Full Text] [Related]
4. Patterns of consultation and treatment of patients with hepatocellular carcinoma presenting to a large academic medical center in the US.
Stacy S; Hyder O; Cosgrove D; Herman JM; Kamel I; Geschwind JF; Gurakar A; Anders R; Cameron A; Pawlik TM
J Gastrointest Surg; 2013 Sep; 17(9):1600-8. PubMed ID: 23780638
[TBL] [Abstract][Full Text] [Related]
5. Travel distance and overall survival in hepatocellular cancer care.
Siegel JB; Allen S; Engelhardt KE; Morgan KA; Lancaster WP
Am J Surg; 2021 Sep; 222(3):584-593. PubMed ID: 33413878
[TBL] [Abstract][Full Text] [Related]
6. Association of socioeconomics, surgical therapy, and survival of early stage hepatocellular carcinoma.
Peters NA; Javed AA; He J; Wolfgang CL; Weiss MJ
J Surg Res; 2017 Apr; 210():253-260. PubMed ID: 28457336
[TBL] [Abstract][Full Text] [Related]
7. Impact of Facility Type and Surgical Volume on 10-Year Survival in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma.
Chapman BC; Paniccia A; Hosokawa PW; Henderson WG; Overbey DM; Messersmith W; McCarter MD; Gleisner A; Edil BH; Schulick RD; Gajdos C
J Am Coll Surg; 2017 Mar; 224(3):362-372. PubMed ID: 27923615
[TBL] [Abstract][Full Text] [Related]
8. Outcomes After Resection of Hepatocellular Carcinoma: Intersection of Travel Distance and Hospital Volume.
Beal EW; Mehta R; Merath K; Tsilimigras DI; Hyer JM; Paredes A; Dillhoff ME; Cloyd J; Ejaz A; Pawlik TM
J Gastrointest Surg; 2019 Jul; 23(7):1425-1434. PubMed ID: 31069637
[TBL] [Abstract][Full Text] [Related]
9. Facility Type is Associated with Margin Status and Overall Survival of Patients with Resected Intrahepatic Cholangiocarcinoma.
Lee GC; Gamblin TC; Fong ZV; Ferrone CR; Goyal L; Lillemoe KD; Blaszkowsky LS; Tanabe KK; Qadan M
Ann Surg Oncol; 2019 Nov; 26(12):4091-4099. PubMed ID: 31368018
[TBL] [Abstract][Full Text] [Related]
10. Volume-outcome associations after major hepatectomy for hepatocellular carcinoma: a nationwide Taiwan study.
Lu CC; Chiu CC; Wang JJ; Chiu YH; Shi HY
J Gastrointest Surg; 2014 Jun; 18(6):1138-45. PubMed ID: 24733257
[TBL] [Abstract][Full Text] [Related]
11. Surgical resection of early stage hepatocellular carcinoma improves patient survival at safety net hospitals.
Vitiello GA; Wang A; Lee RM; Russell MC; Yopp A; Ryon EL; Goel N; Luu S; Hsu C; Silberfein E; Correa-Gallego C; Berman RS; Lee AY
J Surg Oncol; 2021 Mar; 123(4):963-969. PubMed ID: 33497478
[TBL] [Abstract][Full Text] [Related]
12. Surrogate indicators of quality are associated with survival following surgical treatment for hepatocellular carcinoma.
Roife D; Santamaria-Barria JA; Kao LS; Ko TC; Wray CJ
J Surg Oncol; 2018 Sep; 118(3):463-468. PubMed ID: 30196558
[TBL] [Abstract][Full Text] [Related]
13. Closing the gap: Contribution of surgical best practices to outcome differences between high- and low-volume centers for lung cancer resection.
von Itzstein MS; Lu R; Kernstine KH; Halm EA; Wang S; Xie Y; Gerber DE
Cancer Med; 2020 Jun; 9(12):4137-4147. PubMed ID: 32319225
[TBL] [Abstract][Full Text] [Related]
14. Survival Benefit of Liver Transplantation Versus Resection for Hepatocellular Carcinoma: Impact of MELD Score.
Vitale A; Huo TL; Cucchetti A; Lee YH; Volk M; Frigo AC; Cescon M; Tuci F; Pinna AD; Cillo U
Ann Surg Oncol; 2015; 22(6):1901-7. PubMed ID: 25234023
[TBL] [Abstract][Full Text] [Related]
15. Multimodal cancer care in poor prognosis cancers: Resection drives long-term outcomes.
Healy MA; Yin H; Wong SL
J Surg Oncol; 2016 May; 113(6):599-604. PubMed ID: 26953166
[TBL] [Abstract][Full Text] [Related]
16. Predictors of Survival in Hepatocellular Carcinoma Patients.
Gokcan H; Savaş N; Oztuna D; Moray G; Boyvat F; Haberal M
Ann Transplant; 2015 Oct; 20():596-603. PubMed ID: 26438974
[TBL] [Abstract][Full Text] [Related]
17. Disparate Practice Patterns and Survival Outcomes: The Impact of Centralization of Cancer Care for Adrenocortical Carcinoma in the United States.
Stone BV; Tallman JE; Moses KA
J Urol; 2021 Oct; 206(4):866-872. PubMed ID: 34032493
[TBL] [Abstract][Full Text] [Related]
18. Sociodemographic Characteristics as Predictors of Outcomes in Hepatocellular Carcinoma: A Retrospective Cohort Study.
Beutler BD; Ulanja MB; Krishan R; Aluru V; Ndukwu ML; Hagen MM; Dupin ZD; Willyard CE; Moody AE; Boampong-Konam K; Zell SC
Cancer Control; 2020; 27(1):1073274820956615. PubMed ID: 32951450
[TBL] [Abstract][Full Text] [Related]
19. Single HCC in cirrhotic patients: liver resection or liver transplantation? Long-term outcome according to an intention-to-treat basis.
Sapisochin G; Castells L; Dopazo C; Bilbao I; Minguez B; Lázaro JL; Allende H; Balsells J; Caralt M; Charco R
Ann Surg Oncol; 2013 Apr; 20(4):1194-202. PubMed ID: 22965574
[TBL] [Abstract][Full Text] [Related]
20. Trends in practice patterns and outcomes: A decade of sarcoma care in the United States.
Song Y; Ecker BL; Tang R; Maggino L; Roses RE; DeMatteo RP; Fraker DL; Karakousis GC
Surg Oncol; 2019 Jun; 29():168-177. PubMed ID: 31196484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
